Geneticure Email Format
Biotechnology ResearchUnited States2-10 Employees
Geneticure is a United States-based biotechnology research company focused on personalizing care for chronic and high-risk diseases by providing clinicians with tools tailored to individual patients. It uses genomics and integrative physiology to develop tests that help guide therapy, aiming to improve patient outcomes while reducing costs. The work is underpinned by clinical and economic evidence, reflecting a focus on avoiding wasted healthcare resources and preventable loss of life. Its scientific team comes from Mayo Clinic, the University of Minnesota, and the University of Arizona, while its business leadership draws from Target Corporation, Mayo Clinic, and Assurex Health. The company targets clinicians and healthcare organizations interested in data-informed approaches to treatment personalization. In February 2022, Geneticure launched patent-pending technology aimed at improving blood pressure reductions in renal denervation patients.